Article

The Challenges Facing Abuse-Deterrent Opioids

Conference|PAINWeek Conference

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the challenges facing abuse-deterrent opioids as their manufacturers attempt to bring them to market.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the challenges facing abuse-deterrent opioids as their manufacturers attempt to bring them to market.

Related Videos
Woman experiencing pain related to recurrent pericarditis -- Image credit: Art_Photo | stock.adobe.com
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Related Content
Pharmacists as Gatekeepers: Expanding Access to Medication Abortion at a Crossroads
February 22nd 2025

Pharmacists as Gatekeepers: Expanding Access to Medication Abortion at a Crossroads

John Marc Tallegrand Jr, PharmD, RPh
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Key Sessions and Opportunities for Pharmacists at the AACR Immunotherapy Conference
February 21st 2025

Key Sessions and Opportunities for Pharmacists at the AACR Immunotherapy Conference

Alana Hippensteele, Lead Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
FDA approval stamp for chenodiol -- Image credit: Olivier Le Moal | stock.adobe.com
Published: February 21st 2025 | Updated: February 21st 2025

Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval

Gillian McGovern, Associate Editor
Young child holding peanuts -- Image credit: MadameMoustache | stock.adobe.com
February 21st 2025

VP250 Is Safe and Effective Treatment for Young Children With Peanut Allergy

Gillian McGovern, Associate Editor